Ardelyx (ARDX) Capital Expenditures (2013 - 2026)
Ardelyx (ARDX) reported Capital Expenditures of $69000.0 for Q1 2026, down 78.77% on a YoY basis from $325000.0 in Q1 2025, and down 80.89% quarter-over-quarter from $361000.0 in Q4 2025.
Ardelyx (ARDX) Capital Expenditures (2013 - 2026) Analysis & Trends
Ardelyx has reported Capital Expenditures for 14 years, with the latest figure at $69000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 78.77% year-over-year to $69000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 4.22% YoY), and the FY2025 full-year result was $1.5 million, up 47.58% from the prior year.
- Capital Expenditures for Q1 2026 stood at $69000.0, down from $361000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $650000.0 in Q2 2025, with the low at $14000.0 in Q1 2023.
- Historically, Capital Expenditures has averaged $212214.3 across 5 years, with a median of $143500.0 in 2024.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 1279.07% — and 2026, when it slumped 78.77%.
- Ardelyx's Capital Expenditures stood at $55000.0 in 2022, then declined by 21.82% to $43000.0 in 2023, then jumped by 1279.07% to $593000.0 in 2024, then tumbled by 39.12% to $361000.0 in 2025, then plunged by 80.89% to $69000.0 in 2026.
- The last three Capital Expenditures figures came in at $69000.0 (Q1 2026), $361000.0 (Q4 2025), and $156000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 593,000.00 |
| Dec 31, 2024 | 593,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |